Earnings Feed
Start Free
Home/Filings/4/0001181152-10-000002
4//SEC Filing

BONDURANT STUART 4

Accession 0001181152-10-000002

CIK 0001003124other
View on SEC.govCompany Profile

Filed

May 20, 8:00 PM ET

Accepted

May 21, 12:58 PM ET

Size

12.6 KB

Accession

0001181152-10-000002

Insider Transaction Report

Form 4
Period: 2010-05-20
PHARMACEUTICAL PRODUCT DEVELOPMENT INCPPDI
BONDURANT STUART
Director
Transactions
  • Award

    Stock Options (to buy)

    2010-05-20+10,140→ 10,140 total
    Exercise: $25.38From: 2010-05-20Exp: 2020-05-20→ Common Stock (10,140 underlying)
Holdings

  • Common Stock

    17,844

  • Stock Options (to buy)

    Exercise: $33.82From: 2007-05-16Exp: 2017-05-16→ Common Stock (6,126 underlying)
    6,126

  • Stock Options (to buy)

    Exercise: $23.79From: 2005-05-18Exp: 2015-05-17→ Common Stock (5,458 underlying)
    5,458

  • Stock Options (to buy)

    Exercise: $19.86From: 2009-05-20Exp: 2019-05-20→ Common Stock (13,577 underlying)
    13,577

  • Stock Options (to buy)

    Exercise: $42.77From: 2008-05-21Exp: 2018-05-20→ Common Stock (6,265 underlying)
    6,265

  • Stock Options (to buy)

    Exercise: $35.38From: 2006-05-17Exp: 2016-05-16→ Common Stock (3,973 underlying)
    3,973

Documents

1 file

Issuer

PHARMACEUTICAL PRODUCT DEVELOPMENT INC

CIK 0001003124

→
Entity typeother

Related Parties

1
  • filerCIK 0001181152

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 12:58 PM ET
Size
12.6 KB
View on SEC.gov